Immediate Impact
1 from Science/Nature 66 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Jasmien Wellens being referenced
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jasmien Wellens | 290 | 207 | 142 | 28 | 458 | |
| Jasmien Cornillie | 319 | 105 | 204 | 25 | 452 | |
| Ann W. Gramza | 175 | 135 | 193 | 21 | 535 | |
| Séverine Tabone‐Eglinger | 224 | 213 | 87 | 28 | 474 | |
| Sangjeong Ahn | 246 | 140 | 176 | 36 | 463 | |
| Benjamin L. Green | 100 | 85 | 151 | 26 | 466 | |
| Yoshinori Hirashima | 238 | 98 | 334 | 29 | 566 | |
| Shinichi Hirooka | 145 | 79 | 135 | 31 | 421 | |
| Elisa Pastore | 246 | 24 | 156 | 19 | 541 | |
| Yasuo Hosouchi | 205 | 128 | 218 | 41 | 569 | |
| Seong Woo Hong | 121 | 46 | 227 | 26 | 441 |
All Works
Loading papers...